News Formal

Here are some of the companies saying weight loss drugs could impact their business

  • 📰 CNBC
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 72%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

CNBC Pro screened earnings call transcripts to see how a range of corporations are faring as the popularity of the treatments grow.

The impact of new weight loss treatments is being felt well beyond the health-care industry . Analysts used the ritual of quarterly earnings calls to probe companies on whether their businesses were being helped — or hampered by — the latest trend. Drugs that mimic gut hormones like glucagon-like peptide-1, or GLP-1, were first used to treat diabetes, but have gained favor as obesity treatments.

Cardinal Health also said the medications provided a tailwind to its revenue for another quarter. The company raised its fiscal 2024 pharmaceutical sales outlook, citing help from the drugs. Employers watch health-care costs More than 40% of the U.S. adult population is considered obese, and some worry health-care costs will rise rapidly as the drugs become widely used. Some companies already bar weight loss medications from their insurance plans to keep costs down.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 12. in JP
 

コメントありがとうございます。コメントは審査後に公開されます。

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

CNBC Daily Open: Treasury yields are putting pressure on stocksRising U.S. Treasury yields are straining stocks. And with rates possibly going higher if inflation resurges, yields could climb further still.
ソース: nbcchicago - 🏆 545. / 51 続きを読む »

CNBC Daily Open: Stocks are under pressure from Treasury yieldsRising U.S. Treasury yields are straining stocks. And with rates possibly going higher if inflation resurges, yields could climb further still.
ソース: CNBC - 🏆 12. / 72 続きを読む »

Wall Street's official stock market outlook — The latest CNBC Market Strategist SurveyWhere do the sharpest minds on Wall Street believe the market is headed? The CNBC PRO exclusive Market Strategist Survey is a roundup of year-end targets for the S&P 500.
ソース: CNBC - 🏆 12. / 72 続きを読む »